Efficacy of an extended-release tilmicosin preparation and tulathromycin in the treatment of bovine respiratory disease
Main Article Content
Abstract
A trial to evaluate the treatment of bovine respiratory disease (BRD) was established with tulathromycin (Tul-group) and tilmicosin (Til-group). This latter antibacterial drug is pharmaceutically prepared for 8-10 d sustained release. The challenge was carried out with spontaneously BRD-affected bulls, divided into Til-group (ɳ=44) and Tul-group (ɳ=50). Bulls were treated only once with either antibacterial drugs. Bacteriological analysis, arterial and venous blood chemistry, gasometrical parameters, and body temperature were obtained before and after treatment. The clinical cure rate was registered on days 7, 15, and 30. No mortality was observed. Clinical cure was statistically undistinguishable on these days (P> 0.05), and in both groups, all animals were considered healthy until day 30. Only customary pathogens were isolated i.e., Mannhemia hemolytica 38.88% (70/180), Pasteurella multocida 26.11% (47/180), Histophilus somni 18.33% (33/180, and Trueperella pyogenes 16.66% (30/180).
Article Details
License

Veterinaria México OA by Facultad de Medicina Veterinaria y Zootecnia - Universidad Nacional Autónoma de México is licensed under a Creative Commons Attribution 4.0 International Licence.
Based on a work at http://www.revistas.unam.mx
- All articles in Veterinaria México OA re published under the Creative Commons Attribution 4.0 Unported (CC-BY 4.0). With this license, authors retain copyright but allow any user to share, copy, distribute, transmit, adapt and make commercial use of the work, without needing to provide additional permission as long as appropriate attribution is made to the original author or source.
- By using this license, all Veterinaria México OAarticles meet or exceed all funder and institutional requirements for being considered Open Access.
- Authors cannot use copyrighted material within their article unless that material has also been made available under a similarly liberal license.